EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain

Silke Zimmermann, Akash Mathew, Olga Bondareva, Ahmed Elwakiel, Klarina Waldmann, Shihai Jiang, Rajiv Rana, Kunal Singh, Shrey Kohli, Khurrum Shahzad, Ronald Biemann, Thomas Roskoden und 7 weitere

Kidney International · 2024

DOI: 10.1016/j.kint.2024.06.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2024. Verfasst von Silke Zimmermann und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital; Leipzig, Germany. Electronic address: silke.zimm…. Hauptthemen laut MEDLINE: Microglia, Renal Insufficiency, Chronic, Potassium, Inflammasomes. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DAAD, Deutsche Forschungsgemeinschaft, Second Decade Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cognitive impairment is common in extracerebral diseases such as chronic kidney disease (CKD). Kidney transplantation reverses cognitive impairment, indicating that cognitive impairment driven by CKD is therapeutically amendable. However, we lack mechanistic insights allowing development of targeted therapies. Using a combination of mouse models (including mice with neuron-specific IL-1R1 deficiency), single cell analyses (single-nuclei RNA-sequencing and single-cell thallium autometallography), human samples and in vitro experiments we demonstrate that microglia activation impairs neuronal potassium homeostasis and cognition in CKD. CKD disrupts the barrier of brain endothelial cells in vitro and the blood-brain barrier in vivo, establishing that the uremic state modifies vascular permeability in the brain. Exposure to uremic conditions impairs calcium homeostasis in microglia, enhances microglial potassium efflux via the calcium-dependent channel KCa3.1, and induces p38-MAPK associated IL-1β maturation in microglia. Restoring potassium homeostasis in microglia using a KCa3.1-specific inhibitor (TRAM34) improves CKD-triggered cognitive impairment. Likewise, inhibition of the IL-1β receptor 1 (IL-1R1) using anakinra or genetically abolishing neuronal IL-1R1 expression in neurons prevent CKD-mediated reduced neuronal potassium turnover and CKD-induced impaired cognition. Accordingly, in CKD mice, impaired cognition can be ameliorated by either preventing microglia activation or inhibiting IL-1R-signaling in neurons. Thus, our data suggest that potassium efflux from microglia triggers their activation, which promotes microglia IL-1β release and IL-1R1-mediated neuronal dysfunction in CKD. Hence, our study provides new mechanistic insight into cognitive impairment in association with CKD and identifies possible new therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaRenal Insufficiency, ChronicPotassiumInflammasomesBrainAnimalsMiceHumansDisease Models, AnimalBlood-Brain BarrierInterleukin-1betaCognitive DysfunctionMaleIntermediate-Conductance Calcium-Activated Potassium ChannelsMice, KnockoutMice, Inbred C57BLNeuronsEndothelial CellsReceptors, Interleukin-1 Type I

Stichwörter der Autor:innen

chronic kidney diseasecognitive impairmentcytokinesmicroglia-neuron crosstalkpotassium flux

Substanzen

PotassiumInflammasomesInterleukin-1betaIntermediate-Conductance Calcium-Activated Potassium ChannelsIL1R1 protein, mouseReceptors, Interleukin-1 Type I

Autor:innen und Institutionen

  • Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital; Leipzig, Germany. Electronic address: silke.zimmermann@medizin.uni-leipzig.de.
  • Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital; Leipzig, Germany.
  • Helmholtz Institute for Metabolic, Obesity and Vascular Research (Hl-MAG) of the Helmholtz Center Munich, Leipzig, Germany.
  • Institute of Clinical Chemistry and Pathobiochemistry, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
  • Institute of Anatomy, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
  • Institute of Anatomy, Brandenburg Medical School, Neuruppin, Germany.

Förderung

  • DAAD
  • Deutsche Forschungsgemeinschaft
  • Second Decade Society

Zitieren

APA

Zimmermann, S., Mathew, A., Bondareva, O., Elwakiel, A., Waldmann, K., Jiang, S., Rana, R., Singh, K., Kohli, S., Shahzad, K., Biemann, R., Roskoden, T., Storsberg, S. D., Mawrin, C., Krügel, U., Bechmann, I., Goldschmidt, J., Sheikh, B. N., & Isermann, B. (2024). Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain. Kidney International. https://doi.org/10.1016/j.kint.2024.06.028

Vancouver

Zimmermann S, Mathew A, Bondareva O, Elwakiel A, Waldmann K, Jiang S, et al. Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain. Kidney International. 2024. doi:10.1016/j.kint.2024.06.028

BibTeX
@article{Zimmermann2024,
  author = {Zimmermann, Silke and Mathew, Akash and Bondareva, Olga and Elwakiel, Ahmed and Waldmann, Klarina and Jiang, Shihai and Rana, Rajiv and Singh, Kunal and Kohli, Shrey and Shahzad, Khurrum and Biemann, Ronald and Roskoden, Thomas and Storsberg, Silke Diana and Mawrin, Christian and Krügel, Ute and Bechmann, Ingo and Goldschmidt, Jürgen and Sheikh, Bilal N and Isermann, Berend},
  title = {Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain},
  journal = {Kidney International},
  year = {2024},
  doi = {10.1016/j.kint.2024.06.028}
}
Kostenlos starten →